SHE:002940 - Zhejiang AngliKang Pharmaceutical Co Ltd

Zhejiang Anglikang Pharmaceuti
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	314.85M -1.3%	353.16M 12.2%	393.49M 11.4%	338.21M -14.0%	365.58M 8.1%	359.33M -1.7%	505.32M 40.6%	424.51M -16.0%	418.78M -1.3%	343.69M -17.9%	438.88M 27.7%	407.99M -7.0%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	87.82M -20.0%	154.5M 75.9%	135.67M -12.2%	132.13M -2.6%	151.01M 14.3%	146.09M -3.3%	241.32M 65.2%	230.42M -4.5%	208.28M -9.6%	208.4M 0.1%	253.41M 21.6%	245.86M -3.0%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	227.03M 8.6%	198.65M -12.5%	257.82M 29.8%	206.08M -20.1%	214.57M 4.1%	213.24M -0.6%	264.01M 23.8%	194.09M -26.5%	210.5M 8.5%	135.29M -35.7%	185.47M 37.1%	162.13M -12.6%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	270.95M -5.0%	321.7M 18.7%	340.93M 6.0%	295.07M -13.5%	326.8M 10.8%	330.81M 1.2%	470.7M 42.3%	368.63M -21.7%	346.23M -6.1%	328.5M -5.1%	366.17M 11.5%	358.24M -2.2%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	183.13M 4.4%	167.2M -8.7%	205.25M 22.8%	162.93M -20.6%	175.79M 7.9%	184.72M 5.1%	229.38M 24.2%	138.22M -39.7%	137.94M -0.2%	120.1M -12.9%	112.76M -6.1%	112.38M -0.3%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	43.9M 30.1%	31.46M -28.3%	52.56M 67.1%	43.14M -17.9%	38.78M -10.1%	28.52M -26.5%	34.62M 21.4%	55.87M 61.4%	72.55M 29.9%	15.19M -79.1%	72.72M 378.6%	49.75M -31.6%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	75.86M -	-	-	-	86.22M -	-	-	-	127.37M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	32.8M 0.0%	9.61M -70.7%	44.65M 364.4%	39.09M -12.5%	40.02M 2.4%	29.17M -27.1%	19.02M -34.8%	47.07M 147.5%	57.16M 21.4%	5.57M -90.3%	28.58M 413.5%	28.22M -1.3%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.162 0%	0.048 -70.6%	0.229 381.5%	0.2 -12.7%	0.2 0%	0.14 -30%	0.1 -28.6%	0.23 130%	0.29 26.1%	0.02 -93.1%	0.15 650%	0.14 -6.7%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.162 0%	0.048 -70.6%	0.229 381.5%	0.2 -12.7%	0.2 0%	0.14 -30%	0.1 -28.6%	0.23 130%	0.29 26.1%	0.02 -93.1%	0.15 650%	0.14 -6.7%